Gerald R. Ewoldt

Array ( [id] => 7303240 [patent_doc_number] => 20040115217 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-17 [patent_title] => 'Bystander suppression of autoimmune diseases' [patent_app_type] => new [patent_app_number] => 10/639286 [patent_app_country] => US [patent_app_date] => 2003-08-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 39 [patent_no_of_words] => 15244 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0115/20040115217.pdf [firstpage_image] =>[orig_patent_app_number] => 10639286 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5872903 [patent_doc_number] => 20060165681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Antibodies' [patent_app_type] => utility [patent_app_number] => 10/523295 [patent_app_country] => US [patent_app_date] => 2003-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 15558 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0165/20060165681.pdf [firstpage_image] =>[orig_patent_app_number] => 10523295 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7166552 [patent_doc_number] => 20040077023 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-04-22 [patent_title] => 'Method for diagnosing multiple sclerosis' [patent_app_type] => new [patent_app_number] => 10/634309 [patent_app_country] => US [patent_app_date] => 2003-08-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 11443 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 45 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0077/20040077023.pdf [firstpage_image] =>[orig_patent_app_number] => 10634309 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7470581 [patent_doc_number] => 20040096842 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-05-20 [patent_title] => 'Molecules involved in the regulation of insulin resistance syndrome (irs)' [patent_app_type] => new [patent_app_number] => 10/362607 [patent_app_country] => US [patent_app_date] => 2003-08-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 10144 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20040096842.pdf [firstpage_image] =>[orig_patent_app_number] => 10362607 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7276278 [patent_doc_number] => 20040235729 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-25 [patent_title] => 'Synthethic peptides and pharmaceutical compositions comprising them for the treatment of systemic lupus erythematosus' [patent_app_type] => new [patent_app_number] => 10/620621 [patent_app_country] => US [patent_app_date] => 2003-07-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 11405 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 35 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0235/20040235729.pdf [firstpage_image] =>[orig_patent_app_number] => 10620621 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7316782 [patent_doc_number] => 20040224009 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Devices comprising artificial antigen-presenting cellls' [patent_app_type] => new [patent_app_number] => 10/614639 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 42107 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 3 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224009.pdf [firstpage_image] =>[orig_patent_app_number] => 10614639 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7230996 [patent_doc_number] => 20050079208 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Methods of modulating antigen-specific T cell activity' [patent_app_type] => utility [patent_app_number] => 10/614414 [patent_app_country] => US [patent_app_date] => 2003-07-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 37 [patent_figures_cnt] => 37 [patent_no_of_words] => 41560 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0079/20050079208.pdf [firstpage_image] =>[orig_patent_app_number] => 10614414 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5726377 [patent_doc_number] => 20060057137 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-03-16 [patent_title] => 'Glp-1 and methods for treating diabetes' [patent_app_type] => utility [patent_app_number] => 10/517563 [patent_app_country] => US [patent_app_date] => 2003-07-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 14713 [patent_no_of_claims] => 78 [patent_no_of_ind_claims] => 30 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0057/20060057137.pdf [firstpage_image] =>[orig_patent_app_number] => 10517563 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7289542 [patent_doc_number] => 20040110283 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-06-10 [patent_title] => 'Induction of tumor and viral immunity using antigen presenting cell co-culture products and fusion products' [patent_app_type] => new [patent_app_number] => 10/608424 [patent_app_country] => US [patent_app_date] => 2003-06-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6473 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 58 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0110/20040110283.pdf [firstpage_image] =>[orig_patent_app_number] => 10608424 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639485 [patent_doc_number] => 20030212041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Facilitation of wound healing with CM101/GBS toxin' [patent_app_type] => new [patent_app_number] => 10/464001 [patent_app_country] => US [patent_app_date] => 2003-06-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5792 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212041.pdf [firstpage_image] =>[orig_patent_app_number] => 10464001 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 80678 [patent_doc_number] => 07744893 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-06-29 [patent_title] => 'T cell receptor CDR3 sequences associated with multiple sclerosis and compositions comprising same' [patent_app_type] => utility [patent_app_number] => 10/520296 [patent_app_country] => US [patent_app_date] => 2003-06-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10684 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 11 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/744/07744893.pdf [firstpage_image] =>[orig_patent_app_number] => 10520296 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7134954 [patent_doc_number] => 20040043483 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-03-04 [patent_title] => 'Novel tolerogenic dendritic cells and therapeutic uses therefor' [patent_app_type] => new [patent_app_number] => 10/455237 [patent_app_country] => US [patent_app_date] => 2003-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 12714 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0043/20040043483.pdf [firstpage_image] =>[orig_patent_app_number] => 10455237 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7378965 [patent_doc_number] => 20040028683 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Modulators of p85 expression' [patent_app_type] => new [patent_app_number] => 10/452847 [patent_app_country] => US [patent_app_date] => 2003-06-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 10014 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 8 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0028/20040028683.pdf [firstpage_image] =>[orig_patent_app_number] => 10452847 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7308742 [patent_doc_number] => 20040142387 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-22 [patent_title] => 'Mutants of GAD65 and Ian5 relating to diabetes' [patent_app_type] => new [patent_app_number] => 10/449741 [patent_app_country] => US [patent_app_date] => 2003-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 24777 [patent_no_of_claims] => 50 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20040142387.pdf [firstpage_image] =>[orig_patent_app_number] => 10449741 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6729635 [patent_doc_number] => 20030185825 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-10-02 [patent_title] => 'Novel immunotoxins and methods of inducing immune tolerance' [patent_app_type] => new [patent_app_number] => 10/435567 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 27703 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0185/20030185825.pdf [firstpage_image] =>[orig_patent_app_number] => 10435567 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6639028 [patent_doc_number] => 20030212000 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-11-13 [patent_title] => 'Immunoprotective methods for beta cell neogenesis' [patent_app_type] => new [patent_app_number] => 10/434906 [patent_app_country] => US [patent_app_date] => 2003-05-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 15049 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0212/20030212000.pdf [firstpage_image] =>[orig_patent_app_number] => 10434906 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7019272 [patent_doc_number] => 20050221291 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-06 [patent_title] => 'Dc-sign isoforms, related compositions and methods for their use in disease therapy' [patent_app_type] => utility [patent_app_number] => 10/513082 [patent_app_country] => US [patent_app_date] => 2003-05-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 31 [patent_figures_cnt] => 31 [patent_no_of_words] => 40779 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0221/20050221291.pdf [firstpage_image] =>[orig_patent_app_number] => 10513082 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 7386608 [patent_doc_number] => 20040029803 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-02-12 [patent_title] => 'Use of the long pentraxin ptx3 for the preparation of medicament for the prevention and cure of autoimmune pathologies' [patent_app_type] => new [patent_app_number] => 10/415413 [patent_app_country] => US [patent_app_date] => 2003-04-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2742 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0029/20040029803.pdf [firstpage_image] =>[orig_patent_app_number] => 10415413 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 5759617 [patent_doc_number] => 20060210562 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-21 [patent_title] => 'Treatment of type 1 diabetes before and after expression of predisposition markers' [patent_app_type] => utility [patent_app_number] => 10/510411 [patent_app_country] => US [patent_app_date] => 2003-04-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 20202 [patent_no_of_claims] => 46 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0210/20060210562.pdf [firstpage_image] =>[orig_patent_app_number] => 10510411 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6797477 [patent_doc_number] => 20030176351 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-09-18 [patent_title] => 'Peptides and peptide analogues designed from a diabetes-associated autoantigen, and methods for their use in the treatment and prevention of diabetes' [patent_app_type] => new [patent_app_number] => 10/403980 [patent_app_country] => US [patent_app_date] => 2003-03-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 11578 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0176/20030176351.pdf [firstpage_image] =>[orig_patent_app_number] => 10403980 [rel_patent_id] =>[rel_patent_doc_number] =>)